Table 3.
Year | Study Design | No. | Exercise Plan | Key Findings | |
---|---|---|---|---|---|
Nakajima et al. | 2019 | Retrospective, cohort | 76 | 30 days Unsupervised, self-reported exercise | Shorter length of stay in prehabilitation group (23 days vs. 30 days, p = 0.045) |
Ausania et al. | 2019 | Randomised controlled trial | 18 | 2 weeks supervised and unsupervised, aerobic exercise | Reduction in DGE in prehabilitation group (5.6% vs. 40.9%, p = 0.01) |
Florez Bedoya et al. | 2019 | Prospective, cohort | 23 | 15 weeks unsupervised, self-reported, aerobic and resistance exercise | No comment on clinical outcomes Evidence of prehabilitation increasing tumour vascularity. |
Marker et al. | 2018 | Case series | 3 | 12–16 weeks, supervised, physiotherapist reported, hour long, 3× a week | Underpowered |
Parker et al | 2018 | Prospective, cohort | 50 | 60 min per week unsupervised, self-reported aerobic and strengthening exercise | No comment on clinical outcomes Home based exercise programme feasible |
Ngo-Huang et al | 2019 | Prospective, cohort | 50 | 2 weeks, unsupervised, self-reported, hour long aerobic exercise | Prehabilitation associated with improved physical function (6MWT, STS, GS improved from baseline, p = 0.48, 0.03 & 0.08, respectively) and HRQOL (Improved with increased LPA (p = 0.01) |
6MWT = 6 min walk test, STS = Sit to stand, GS = Gait speed, HRQOL = Health Related Quality of Life, LPA = Light physical activity.